Clinical Trial

Thrombotic RIsk FActors in AL-goneurodystrophy

Name: Thrombotic RIsk FActors in AL-goneurodystrophy — clinical trial record (NCT07435207)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRIF-AL

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Trial Details

NCT Number	NCT07435207
Lead Sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions	Algoneurodystrophy
Enrollment	120 participants
Start Date	2026-01-26
Primary Completion	2027-01-31 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-27